Logo
x

Search

Subscribe Now

Chronic

Amgen Reports Results of Aimovig (erenumab-aooe) in P-lV Study for the Treatment of Episodic and Chronic Migraine

Amgen Reports Results of Aimovig (erenumab-aooe) in P-lV Study for the Treatment of Episodic and Chronic Migraine

  • November 9, 2021
Novartis' Asciminib (ABL001) Demonstrate Superiority Over Pfizer's Bosulif in Chronic Myeloid Leukemia Trial

Novartis' Asciminib (ABL001) Demonstrate Superiority Over Pfizer's Bosulif in Chronic Myeloid Leukemia Trial

  • December 9, 2020
Rhythm's Imcivree (setmelanotide) Receives the US FDA's Approval for Chronic Weight Management in Patients with Obesity

Rhythm's Imcivree (setmelanotide) Receives the US FDA's Approval for Chronic Weight Management in Patients with Obesity

  • November 27, 2020
Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receives the US FDA's Fast Track Designation for Chronic Kidney Disease

Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receives the US FDA's Fast Track Designation for Chronic Kidney Dis...

  • March 13, 2020
Janssen Collaborates with Arrowhead for the Initiation of REEF-1 P-IIB Study in Patients with Chronic Hepatitis B Infection

Janssen Collaborates with Arrowhead for the Initiation of REEF-1 P-IIB Study in Patients with Chronic Hepatitis B Infection

  • August 28, 2019
Janssen's Imbruvica (ibrutinib) Receives European Commission Approval for Chronic Lymphocytic Leukaemia and Waldenstrom's Macroglobulinemia in Adults

Janssen's Imbruvica (ibrutinib) Receives European Commission Approval for Chronic Lymphocytic Leukaemia and Waldenstrom's Macroglo...

  • August 14, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.